AIR (Artificial Implant to Restore the Medial Meniscus Function)2 Clinical Investigation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-19

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The AIR2 Study is a multi-center, prospective, interventional clinical trial with the objective to evaluate the safety and performance of the Trammpolin® medial meniscus prosthesis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

AIR (Artificial Implant for Medial Meniscus Replacement) Study

NCT03696836

Meniscectomy Osteo Arthritis Knee

TERMINATED NA

Bio ACL Reconstruction Amnion Collagen Matrix Wrap and Stem Cells

NCT03294759

ACL - Anterior Cruciate Ligament Rupture

ACTIVE_NOT_RECRUITING NA

Early Artificial Lateral Prosthesis

NCT06705985

Post-Meniscectomy Pain Syndrome

NOT_YET_RECRUITING NA

RAHM Foundation Retrospective Study of Various Diseases

NCT02359786

Pain, Spinal Surgeries, Hip and Knee Joint Replacement, Adverse Events

UNKNOWN

Evaluation of Triathlon - A New Total Knee Prosthesis System - Triathlon PA vs. Triathlon Pressfit

NCT03198533

Arthroplasty, Replacement, Knee

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Trammpolin® meniscus prosthesis is intended to replace the native medial meniscus to provide pain relief in the medial compartment of the knee joint, when this is caused by medial partial meniscectomy.

Patients who meet the inclusion/exclusion criteria and who are implanted with the Trammpolin® medial meniscus prosthesis will be followed for 2 years. The patient reported outcome measures for knee pain and function, and knee clinical condition by MRI and X-ray is assessed post-operative compared to pre-operative.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Injuries and Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Early feasibility study

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single arm

Implantation of a medial meniscus prosthesis in the medial knee compartment of a post medial meniscectomy knee.

Group Type OTHER

Trammpolin medial meniscus prosthesis

Intervention Type DEVICE

Implantation of the Trammpolin medial meniscus prosthesis in patients with a severe medial meniscus damage

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trammpolin medial meniscus prosthesis

Implantation of the Trammpolin medial meniscus prosthesis in patients with a severe medial meniscus damage

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Has medial compartment knee pain and had a medial partial or total meniscectomy \> 6 months ago. The lack of meniscus tissue is confirmed by patient history and MRI
2. Has a KOOS Pain of ≤ 75 (100 being no pain and the highest attainable score)
3. Is between age 18 and 70 years (inclusive) at the time of screening
4. Has neutral alignment ± 5° of the mechanical axis, i.e., the angle formed by a line drawn from the center of the femoral head to the medial tibial spine and a line drawn from the medial tibial spine to the center of the ankle joint, as confirmed by X-ray
5. Is willing to be implanted with the Trammpolin® medial meniscus prosthesis
6. Is willing and able to comply to the clinical investigation required follow up visits, questionnaires, X-rays and MRI's
7. Is able and willing to understand and sign the clinical investigation Informed Consent Form
8. Is able to read and understand the national language of the country in which the relevant clinical site is located

Exclusion Criteria

1. Has a symptomatic knee because of a tear that could potentially be addressed by a repeat partial meniscectomy
2. Has evidence of a modified Outerbridge Grade IV cartilage loss on the medial tibial plateau or femoral condyle that potentially could contact a Trammpolin® medial meniscus prosthesis
3. Has lateral compartment pain and Grade III or Grade IV modified Outerbridge cartilage score in the lateral compartment
4. Has a varus or valgus knee deformity of \> 5° requiring a tibial or femoral osteotomy
5. Has a varus alignment that is not passively correctable
6. Has a laxity level of more than Grade II (IKDC), primary or secondary to an injury of the anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or lateral collateral ligament (LCL) and/or medial collateral ligament (MCL)
7. Has significant trochlear dysplasia, patellar instability or symptomatic patellar misalignment
8. Has patellar compartment pain and Grade III or Grade IV modified Outerbridge cartilage score in the patellar compartment.
9. Compared to a normal knee, has obvious radiological evidence of medial femoral squaring, anatomical variance in the medial tibial plateau, or irregularly shaped cartilage surface
10. Had an ACL reconstruction performed \< 9 months prior to surgery
11. Has a BMI \> 30 at the time of screening
12. Has a knee flexion contracture \> 10°
13. Has a knee flexion \< 90°
14. Had a previous High Tibial Osteotomy (HTO) \< 1 year ago
15. Has insufficiency fractures or avascular necrosis of the medial compartment
16. Has an active infection or tumor (local or systemic)
17. Has any type of knee joint inflammatory disease including Sjogren's syndrome
18. Has neuropathic knee osteoarthropathy, also known as Charcot joint
19. Has any medical condition that does not allow possible arthroscopy of the knee
20. Has neurological deficit (sensory, motor, or reflex)
21. Is currently involved in another investigation of the lower extremity
22. Anticipates having another lower extremity surgery during the clinical investigation period
23. Has received any corticosteroid knee injections ≤ 3 months prior to surgery
24. Has proven osteoporosis
25. Is on immunostimulating or immunosuppressing agents
26. Has ipsilateral or contralateral lower limb joint conditions that may affect ambulation or KOOS (e.g. have a leg length discrepancy \> 2.5 cm \[1 inch\], causing a noticeable limp)
27. Is a female who is lactating, expecting, or is intending to become pregnant during the clinical investigation period
28. Is mentally incapacitated (incapable of appraising or controlling conduct) or have mental disability (e.g., dementia or Alzheimer's)
29. Has a condition or be in a situation that, in the Investigator's opinion, may confound the clinical investigation results, may risk the safety of the patient, or may interfere significantly with the subject's participation in the clinical investigation

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No